Myelofibrosis: A Challenging Preclinical Model with an Unmet Clinical Need – Presentation by TD2
Time: 2:00 pm
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 1 PM
Details:
- TD2 overview with updates in services and technology.
- General overview of myelofibrosis clinically and preclinically.
- TD2 models for myelofibrosis and how they can be used to drive programs forward
